Table 1.
Clinical manifestations and clinical features of SLE patients at the time of the study.
| Characteristics | SLE (n = 49) |
|---|---|
| Age (years) | 34.5 ± 14.3 |
| Female : male | 44 : 5 |
| Clinical manifestations no. (%) | |
| Malar rash/discoid rash | 32 (65.3) |
| Photosensitivity | 16 (32.7) |
| Oral ulcer | 12 (24.5) |
| Arthritis/arthralgia | 38 (77.6) |
| Autoimmune hemolytic anemia | 35 (71.4) |
| Leukopenia | 18 (36.7) |
| Lymphopenia | 34 (69.3) |
| Immune thrombocytopenia | 23 (46.9) |
| Renal involvement | 41 (83.7) |
| Neurological involvement | 6 (12.2) |
| SLEDAI | 19.2 ± 6.7 |
| Serological features (%) | |
| Anti-dsDNA Abs | 32 |
| Serum C3 (g/L) | 0.45 ± 0.23 |
| Serum C4 (g/L) | 0.09 ± 0.07 |
Abbreviations: SLE: systemic lupus erythematosus; SLEDAI: SLE disease activity index; dsDNA: double-stranded DNA; C3: complement 3; C4: complement 4.